Valuation Charles River Laboratories International, Inc.

Stocks

Market Closed - NYSE Other stock markets 21:00:02 06/07/2026 BST			5-day change	1st Jan Change
231.43 ^USD	+0.32%		+2.60%	+16.02%

07-01	Charles River Laboratories International Insider Sold Shares Worth $16,875,000, According to a Recent SEC Filing	MT
07-01	Argus Raises Price Target on Charles River Laboratories International to $250 From $200, Maintains Buy Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	18,941	11,138	12,252	9,520	10,023	11,147	-	-
Change	-	-41.2%	10%	-22.3%	5.29%	11.22%	-	-
Enterprise Value (EV) ¹	21,366	13,616	14,622	11,565	11,946	12,961	12,536	12,156
Change	-	-36.28%	7.39%	-20.91%	3.29%	8.5%	-3.28%	-3.03%
P/E	49.4x	23.1x	25.9x	931x	-70x	37.7x	25.2x	23.2x
PBR	7.45x	3.75x	3.41x	2.75x	3.17x	3.38x	3.02x	2.74x
PEG	-	0.9x	-9.44x	-9.5x	0x	-0x	0.5x	2.69x
Capitalization / Revenue	5.35x	2.8x	2.97x	2.35x	2.5x	2.9x	2.84x	2.72x
EV / Revenue	6.04x	3.42x	3.54x	2.86x	2.98x	3.37x	3.19x	2.96x
EV / EBITDA	24.3x	13.7x	14.4x	11.6x	12.3x	13.1x	11.9x	10.9x
EV / EBIT	28.8x	16.3x	17.4x	14.3x	15x	15.9x	14.2x	12.8x
EV / FCF	40.2x	46.2x	40x	23.1x	23x	36.8x	32.2x	50.7x
FCF Yield	2.49%	2.17%	2.5%	4.34%	4.34%	2.72%	3.11%	1.97%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	7.6	9.48	9.22	0.2	-2.91	6.135	9.169	9.961
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	3,540	3,976	4,129	4,050	4,015	3,847	3,924	4,105
EBITDA ¹	879.5	990.9	1,013	996.1	971.5	989	1,051	1,118
EBIT ¹	742.1	834	838.8	805.9	793.9	814.1	885	952.9
Net income ¹	391	486.2	474.6	10.3	-144.3	285.1	417.3	447
Net Debt ¹	2,425	2,477	2,370	2,046	1,923	1,814	1,388	1,009
Reference price ²	375.34	218.92	238.84	186.16	203.66	231.43	231.43	231.43
Nbr of stocks (in thousands)	50,464	50,879	51,297	51,136	49,215	48,168	-	-
Announcement Date	16/02/22	22/02/23	14/02/24	19/02/25	18/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	37.72x	3.37x	13.11x	-.--%	11.15B
LONZA GROUP AG	34.97x	6.13x	18.97x	0.94%	50.25B
REVOLUTION MEDICINES, INC.	-23.78x	350.4x	-22.5x	-.--%	40.39B
IQVIA HOLDINGS INC.	25.06x	2.78x	12.01x	-.--%	34.38B
BEONE MEDICINES AG	46.76x	4.69x	29.96x	-.--%	34.4B
CELLTRION, INC.	27.28x	7.84x	19.63x	0.41%	26.32B
MEDPACE HOLDINGS, INC.	33.16x	5.4x	24.58x	-.--%	16.14B
EUROFINS SCIENTIFIC SE	23.86x	2.03x	8.93x	1.12%	13.71B
IONIS PHARMACEUTICALS, INC.	-23.08x	15.14x	-22.65x	-.--%	13.75B
Average	20.22x	44.20x	9.12x	0.27%	26.72B
Weighted average by Cap.	20.59x	63.56x	9.81x	0.31%